Johnson & Johnson JNJ
NYSE JNJ
$269.99 -0.22 (-0.08%)
At close: Sep 18, 2026 · 4:00 PM EDT

Johnson & Johnson (JNJ) Goodwill & Intangibles (2009 - 2026)

Johnson & Johnson's (JNJ) quarterly Goodwill & Intangibles came in at $96.7 billion in Q2 2026, down 1.27% year-over-year from $98.0 billion in Q2 2025, and down 0.93% quarter-over-quarter from $97.6 billion in Q1 2026.

Analysis

Johnson & Johnson (JNJ) Goodwill & Intangibles (2009 - 2026) Analysis & Trends

Johnson & Johnson has disclosed Goodwill & Intangibles across 18 years of filings, most recently posting $96.7 billion for Q2 2026.

  • In Q2 2026, Goodwill & Intangibles fell 1.27% year-over-year to $96.7 billion; the TTM figure through Jun 2026 stood at $96.7 billion (down 1.27% YoY), while the FY2025 annual figure was $99.2 billion, up 21.21% from the prior year.
  • Goodwill & Intangibles came in at $96.7 billion for Q2 2026 at Johnson & Johnson, down from $97.6 billion in the prior quarter.
  • In the past five years, Goodwill & Intangibles ranged from a high of $99.2 billion in Q4 2025 to a low of $70.7 billion in Q4 2023.
  • Average Goodwill & Intangibles over 5 years is $83.8 billion, with a median of $81.8 billion recorded in 2024.
  • Year-over-year, Goodwill & Intangibles fell 23.78% in 2024 and increased 21.21% in 2025.
  • Over 5 years, Goodwill & Intangibles stood at $73.7 billion in 2022, then retreated by 4.05% to $70.7 billion in 2023, then advanced by 15.67% to $81.8 billion in 2024, then climbed by 21.21% to $99.2 billion in 2025, then fell by 2.49% to $96.7 billion in 2026.
  • Per Business Quant data, the three most recent Goodwill & Intangibles figures were $96.7 billion in Q2 2026, $97.6 billion in Q1 2026, and $99.2 billion in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 650.65 Bn 629.89 Bn 17.26 Bn
2 AbbVie 466.34 Bn 459.82 Bn 12.70 Bn
3 Merck 362.11 Bn 355.02 Bn 12.21 Bn
4 Novartis Ag 267.81 Bn 260.52 Bn 11.24 Bn
5 Pfizer 157.31 Bn 145.91 Bn 10.94 Bn
6 Bristol Myers Squibb 128.75 Bn 117.69 Bn 9.25 Bn
7 Sanofi 51.80 Bn 44.84 Bn 10.79 Bn
8 Revolution Medicines 40.91 Bn 40.91 Bn -
9 BeOne Medicines 39.65 Bn 34.55 Bn 1.53 Bn
10 Incyte 25.18 Bn 20.65 Bn 1.57 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 28, 2026 96.71 Bn
Mar 29, 2026 97.62 Bn
Dec 28, 2025 99.18 Bn
Sep 28, 2025 96.79 Bn
Jun 29, 2025 97.95 Bn
Mar 30, 2025 81.22 Bn
Dec 29, 2024 81.82 Bn
Sep 29, 2024 84.29 Bn
Jun 30, 2024 83.98 Bn
Mar 31, 2024 70.90 Bn
Dec 31, 2023 70.73 Bn
Oct 1, 2023 71.15 Bn
Jul 2, 2023 91.69 Bn
Apr 2, 2023 93.02 Bn
Jan 1, 2023 74.54 Bn
Oct 2, 2022 73.72 Bn
Jul 3, 2022 76.57 Bn
Apr 3, 2022 79.36 Bn
Jan 2, 2022 71.83 Bn
Oct 3, 2021 83.35 Bn